ProfileGDS4132 / 229769_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 43% 45% 35% 43% 39% 41% 44% 35% 43% 39% 46% 50% 48% 44% 44% 46% 50% 39% 41% 51% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101113.64543
GSM201543Muscle PCOS pioglitazone 121111.72345
GSM201544Muscle PCOS pioglitazone 16190.641235
GSM201545Muscle PCOS pioglitazone 201119.97443
GSM201829Muscle PCOS pioglitazone 231107.7939
GSM201830Muscle PCOS pioglitazon 251110.76741
GSM201831Muscle PCOS pioglitazone 271117.73544
GSM201832Muscle PCOS pioglitazone 3190.013835
GSM201833Muscle PCOS pioglitazone 41105.08243
GSM201834Muscle PCOS pioglitazone 8198.310139
GSM201835Muscle PCOS after pioglitazone 102107.08646
GSM201836Muscle PCOS after pioglitazone 122123.56450
GSM201837Muscle PCOS after pioglitazone 162111.66248
GSM201838Muscle PCOS after pioglitazone 202103.62344
GSM201839Muscle PCOS after pioglitazone 232108.5444
GSM201840Muscle PCOS after pioglitazone 252116.48446
GSM201841Muscle PCOS after pioglitazone 272119.50250
GSM201842Muscle PCOS after pioglitazone 3282.240839
GSM201843Muscle PCOS after pioglitazone 42103.24141
GSM201844Muscle PCOS after pioglitazone 82134.76351